(6-3-基氯吡啶)-(2,4-二甲基苯基)甲酮, ≥98%

(6-Chloropyridin-3-yl)(2,4-dimethylphenyl)methanone

(6-氨基吡啶-3-基)(2-甲氧苯基)甲酮, ≥98%

(6-Aminopyridin-3-yl)(2-methoxyphenyl)methanone

(7R,8aS)-2-苄基-7-羟基六氢吡咯并[1,2-a]吡嗪-1,4-二酮, 99%

(7R,8aS)-2-Benzyl-7-hydroxyhexahydropyrrolo[1,2-a]pyrazine-1,4-dione

(E)-1-(4-溴苯基)-3-(呋喃-2-基)丙-2-烯-1-酮, 98%

(2E)-1-(4-bromophenyl)-3-(furan-2-yl)prop-2-en-1-one

(E)-2'-羟基-3,4-二甲氧基查耳酮, ≥99%(LC)

(E)-2'-Hydroxy-3,4-dimethoxychalcone

(E)-2-羟基查耳酮, 99%

(E)-2-Hydroxychalcone

(E)-4'-甲基查耳酮, ≥99%(GC)

(E)-4'-Methylchalcone

(E)-4-(4-(三氟甲基)苯基)丁-3-烯-2-酮, 98%

(E)-4-(4-(Trifluoromethyl)phenyl)but-3-en-2-one

(E)-4-己烯-3-酮, ≥99%(GC)

(E)-4-Hexen-3-one

(E)-4-羟基查耳酮, ≥98%(LC&T)

(E)-4-Hydroxychalcone

(E)-壬-3-烯-2-酮, 98%

(E)-Non-3-en-2-one

(R)-(+)-4-(甲氧甲基)-1,3-二氧杂戊环-2-酮, ≥99%(GC)

(R)-(+)-4-(Methoxymethyl)-1,3-dioxolan-2-one

(R)-3-(3-氟-4-硫代吗啉代苯基)-5-(羟甲基)噁唑烷-2-酮, 98%

(R)-3-(3-Fluoro-4-thiomorpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one

(R)-4-羟基-2-(羟基甲基)-2-环戊烯-1-酮, 90%

(R)-4-Hydroxy-2-(hydroxymethyl)-2-cyclopenten-1-one

(R)-4-苯甲基-3-(2-溴乙酰基)噁唑烷-2-酮, 98%

(R)-4-benzyl-3-(2-bromoacetyl)oxazolidin-2-one

(R)-5-(羟甲基)-3-(4-碘苯基)恶唑烷-2-酮, 98%

(R)-5-(Hydroxymethyl)-3-(4-iodophenyl)oxazolidin-2-one

(R)-六氢-1H-吡啶并[1,2-a]吡嗪-1,4(6H)-二酮, 98%

(R)-hexahydro-1H-pyrido[1,2-a]pyrazine-1,4(6H)-dione

(R)-叔丁基 3-(3-甲氧基-3-氧代丙酰基)哌啶-1-羧酸酯, ≥98%

(R)-tert-Butyl 3-(3-methoxy-3-oxopropanoyl)piperidine-1-carboxylate

(S)-(+)-3-羟基-2,2-二甲基环己酮, ≥98%(GC)

(S)-(+)-3-Hydroxy-2,2-dimethylcyclohexanone

(S)-(-)-4-(甲氧甲基)-1,3-二氧杂戊环-2-酮, ≥99%(GC)

(S)-(-)-4-(Methoxymethyl)-1,3-dioxolan-2-one